Document is current
Any future updates will be listed below
-
Authors
Visaggi, Pierfrancesco
Savarino, Edoardo V. https://orcid.org/0000-0002-3187-2894
- License Information
-
More Information
Article History
First Online: 22 December 2025
Competing interests
: P.V. has received lecture or consultancy fees from Apogee Therapeutics, Alfasigma, Malesci, Dr Falk Pharma, Pharmaline and Sanofi. E.V.S. has received lecture or consultancy fees from Abbvie, Aboca, Abivax, Agave, AGPharma, Alfasigma, Apogee, Apoteca, AstraZeneca, Biosline, Bristol-Myers Squibb, CaDiGroup, Celltrion, Dr Falk, EG Stada Group, Eli Lilly, Fenix Pharma, Galapagos, Giuliani, Grunenthal, Johnson & Johnson, JB Pharmaceuticals, Innovamedica/Adacyte, Lionhealth, Malesci, Mayoly Biohealth, Montefarco, Nestlè, Novartis, Omega Pharma, Pfizer, PRO.MED.CS Praha a.s., Rafa, Reckitt Benckiser, Recordati, Sandoz, Sanofi/Regeneron, SILA, Takeda, Tillots and Unifarco.
